<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12163937</article-id><article-id pub-id-type="pmcid-ver">PMC12163937.1</article-id><article-id pub-id-type="pmcaid">12163937</article-id><article-id pub-id-type="pmcaiid">12163937</article-id><article-id pub-id-type="manuscript-id">NIHMS2079409</article-id><article-id pub-id-type="pmid">40319789</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2025.112685</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2079409</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2079409</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Substance-induced mental disorders and discontinuation of medication for opioid use disorder</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Tilhou</surname><given-names initials="AS">Alyssa Shell</given-names></name><degrees>MD PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Grucza</surname><given-names initials="RA">Richard A.</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="KY">Kevin Y.</given-names></name><degrees>MD MPH</degrees><xref rid="A3" ref-type="aff">c</xref></contrib></contrib-group><aff id="A1"><label>a.</label>Department of Family Medicine, Dowling Building, Boston Medical Center, 850 Harrison Ave, Boston, MA, 02118, USA.</aff><aff id="A2"><label>b.</label>Advanced Health Data (AHEAD) Institute, Department of Family and Community Medicine, Saint Louis University, 3545 Lafayette Ave., 4th Floor, St. Louis, MO 63104, USA</aff><aff id="A3"><label>c.</label>Department of Psychiatry, Washington University School of Medicine, 660 S Euclid Ave, St. Louis, MO, 63110, USA</aff><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Alyssa Shell Tilhou MD PhD, <email>alyssa.tilhou@bmc.org</email></corresp><fn id="FN1"><p id="P1"><bold>Email</bold>: Alyssa Tilhou (Assistant Professor of Family Medicine, Boston Medical Center, <email>alyssa.tilhou@bmc.org</email>), Richard Grucza (Professor of Family and Community Medicine, Saint Louis University, <email>Richard.grucza@health.slu.edu</email>); Kevin Xu (Assistant Professor of Psychiatry, Washington University, <email>xukeviny@wustl.edu</email>)</p></fn><fn fn-type="con" id="FN2"><p id="P2"><bold>Contributions</bold>: <italic toggle="yes">Conceptualization</italic>: AST, KYX; <italic toggle="yes">Research Question Development</italic>: AST, KYX, RAG; <italic toggle="yes">Study Design:</italic> AST, KYX, RAG; <italic toggle="yes">Data Curation</italic>: KYX; <italic toggle="yes">Data Management</italic>: KYX; <italic toggle="yes">Formal Analysis</italic>: KYX; <italic toggle="yes">Visualization</italic>: KYX; <italic toggle="yes">Validation</italic>: KYX; <italic toggle="yes">Resources</italic>: KYX; <italic toggle="yes">Supervision</italic>: RAG; <italic toggle="yes">Data Interpretation</italic>: AST, KYX, RAG; <italic toggle="yes">Initial Drafting</italic>: AST, KYX; <italic toggle="yes">Revision and Approval of Manuscript</italic>: AST, KYX, RAG; <italic toggle="yes">Access to Raw Data</italic>: KYX; <italic toggle="yes">Access to Tabulated Data</italic>: AST, KYX, RAG. KYX and AST had final responsibility for the decision to submit for publication.</p></fn><fn fn-type="COI-statement" id="FN6"><p id="P37">Author disclosures</p><p id="P38">The authors have no conflicts of interest or disclosures to declare.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>22</day><month>4</month><year>2025</year></pub-date><volume>272</volume><issue-id pub-id-type="pmc-issue-id">490591</issue-id><fpage>112685</fpage><lpage>112685</lpage><pub-history><event event-type="nihms-submitted"><date><day>15</day><month>05</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>01</day><month>07</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-14 10:25:40.243"><day>14</day><month>06</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2079409.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P3">People with opioid use disorder (OUD) often exhibit psychiatric symptoms representing primary (PMD) and substance induced mental disorders (SIMD). PMD are associated with increased discontinuation of medications for OUD (MOUD). It is unknown if this relationship holds for SIMD.</p></sec><sec id="S2"><title>Objective:</title><p id="P4">To examine the association between SIMD and time to MOUD discontinuation.</p></sec><sec id="S3"><title>Methods:</title><p id="P5">In this retrospective cohort study using the Merative<sup>&#8482;</sup> MarketScan<sup>&#174;</sup> Commercial and Multi-State Medicaid insurance claims Databases (2015-2019), we identified individuals initiating MOUD (buprenorphine, methadone, and extended-release naltrexone) following a 180-day pre-period of continuous enrollment without MOUD. Episodes were classified based on &#8805;1 SIMD diagnosis in this pre-period. We estimated days to MOUD discontinuation using stepwise multivariable Cox regression, adjusting for age, sex, insurance type (Medicaid or Commercial), Charlson Comorbidity Index, MOUD at initiation, co-occurring substance use disorders (SUD), and PMD.</p></sec><sec id="S4"><title>Results:</title><p id="P6">Of 31,134 MOUD initiation episodes, 3.5% exhibited SIMD. Episodes with SIMD demonstrated a higher prevalence (p&lt;.001 for all) of mood and psychotic disorders (42.8 vs 16.4%; 4.0% vs 0.7% respectively) but lower prevalence of anxiety-related disorders (51.3% vs 59.9%) relative to episodes without SIMD. Unadjusted models illustrated a 44% (95%CI:1.34-1.55) increased hazard of MOUD discontinuation associated with SIMD. After adjusting for all covariates but PMD, SIMD retained a 13% increased hazard of MOUD discontinuation (95%CI:1.05-1.21). Adjusting for PMD eliminated this association.</p></sec><sec id="S5"><title>Conclusion:</title><p id="P7">SIMD is associated with reduced time to MOUD discontinuation, which may be accounted for by PMD. Further research on SIMD treatment among individuals with OUD is needed to improve OUD treatment outcomes.</p></sec></abstract><kwd-group><kwd>opioid use disorder</kwd><kwd>medication for opioid use disorder</kwd><kwd>treatment retention</kwd><kwd>treatment discontinuation</kwd><kwd>substance induced mental disorder</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>